Rezension:
Have you got any qualifications? buy designer drugs online usa The company raised its full year GAAP forecast and expects revenue of $4.31 billion and earnings of 77 cents per share, compared to its previously announced revenue of $4.22 billion and earnings of 73 cents per share. It maintained its non-GAAP forecast of $4.25 billion in revenue and earnings of 82 cents per share.
